Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).
- DOI
- 10.1016/j.esmoop.2025.105552
- Published
- 2025 Aug
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2025.105552,
title = {Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).},
author = {Hamann M and Christgen M and Gluz O and Nitz U and Kuemmel S and Braun M and Thill M and Wuerstlein R and Wimberger P and Hartkopf A and Schem C and Zaiss M and Bjelic-Radisic V and Just M and Veselinovic K and Vincent M and Graeser M and Krauss K and Hoffmann O and Lüdtke-Heckenkamp K and Kates RE and Zu Eulenburg C and Jóźwiak K and Burmeister S and Hauptmann M and Baehner F and Schmid P and Kreipe HH and Harbeck N},
year = {2025},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2025.105552},
url = {https://doi.org/10.1016/j.esmoop.2025.105552}
}RIS
TY - JOUR TI - Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292). AU - Hamann M AU - Christgen M AU - Gluz O AU - Nitz U AU - Kuemmel S AU - Braun M AU - Thill M AU - Wuerstlein R AU - Wimberger P AU - Hartkopf A AU - Schem C AU - Zaiss M AU - Bjelic-Radisic V AU - Just M AU - Veselinovic K AU - Vincent M AU - Graeser M AU - Krauss K AU - Hoffmann O AU - Lüdtke-Heckenkamp K AU - Kates RE AU - Zu Eulenburg C AU - Jóźwiak K AU - Burmeister S AU - Hauptmann M AU - Baehner F AU - Schmid P AU - Kreipe HH AU - Harbeck N PY - 2025 JO - ESMO open DO - 10.1016/j.esmoop.2025.105552 UR - https://doi.org/10.1016/j.esmoop.2025.105552 ER -
APA
M, H., M, C., O, G., U, N., S, K., M, B., M, T., R, W., P, W., A, H., C, S., M, Z., V, B., M, J., K, V., M, V., M, G., K, K., O, H., K, L., RE, K., C, Z. E., K, J., S, B., M, H., F, B., P, S., HH, K., & N, H. (2025). Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).. ESMO open. https://doi.org/10.1016/j.esmoop.2025.105552
Source records
- pubmed · retrieved 2026-09-26T14:29:32.707Z